Novartis recruits for vaccines role

Swiss drugs firm Novartis is hunting a director of public affairs for its vaccines and ­diagnostics division, a business it acquired in April from US manufacturer Chiron.

The company said it wants the postholder to ‘identify, influence and shape public health policy and the socio-economic and political environment to support vaccines' public affairs initiatives in the UK'.

Chiron Vaccines made headlines two years ago when production of its flu vaccine was suspended because of fears of bacterial contamination.

It has emerged that upon Novartis's acquisition of Chiron, Europe executive director of policy and public affairs Frances Luff stepped down. She is now ­acting as a freelance ­consultant on public policy.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in